机译:Does real-time artificial intelligence-based visual pathology enhancement of three-dimensional optical coherence tomography scans optimise treatment decision in patients with nAMD? Rationale and design of the RAZORBILL study
Novartis,Novartis Pharma GmbH;
Dept Ophthalmol,Univ Hosp La Candelaria;
Univ Vita Salute Hosp San Raffaele,Univ Vita SaluteMaisonneuve Rosemt Hosp Res Ctr,Univ MontrealDept Ophthalmol,Bon Secours Hosp DublinDept Ophthalmol,St Franzikus HospEye Clin,Univ MilanDept Ophthalmol,Univ UlmNovartis Pharma AGNovartis Pharma GmbH;
imaging; macula; neovascularisation; retina; treatment medical; MACULAR DEGENERATION; RANIBIZUMAB TREATMENT; ACUITY; OUTCOMES; THERAPY;